Company Overview

Update
Founded:
1998
Headquarters:
Newtown, PA
IPO:
Went Public on Jul 5, 2013
Stock:
ONTX
Categories:
Health Care, Biotechnology
Description:
Onconova Therapeutics is a biopharmaceutical company developing small molecule drug candidates for the treatment of cancer.

Detailed Description

Update

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a proprietary chemistry platform, Onconova has created an extensive library of targeted anti-cancer agents designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. Onconova has three product candidates in clinical trials and six active pre-clinical programs.

Onconova seeks to develop products that improve the outcome for cancer patients by directly addressing the disease, its recurrence, and the burden of side-effects associated with current methods of treatment.

Current Team (11)

Update

Past Team (1)

Update

Funding Rounds (4) - $88M

Update

Board Members and Advisors (5)

Update

Offices/Locations (1)

Update
  • Headquarters

    375 Pheasant Run

    Newtown, PA 18940

    USA

Images (1)

Update
  • Ccdfd4444a0c42ebcad167ce32af97e3